373 Treatments for acute decompensated heart failure have significant international variations: an analysis of the randomized interventions with tezosentan (RITZ-1) trial
“…A large-scale trial prospective randomized trial of nesiritide in the treatment of AHF is currently planned to test safety and efficacy. Endothelin antagonists have been studied in the treatment of AHF, but a large randomized trial of tezosentan 1 mg/h versus placebo in 1400 AHF patients with dyspnea was stopped for futility without significant safety concerns (174)(175)(176)(177)(178).…”
Section: Medical Treatment Of Ahf Recommendationsmentioning
“…A large-scale trial prospective randomized trial of nesiritide in the treatment of AHF is currently planned to test safety and efficacy. Endothelin antagonists have been studied in the treatment of AHF, but a large randomized trial of tezosentan 1 mg/h versus placebo in 1400 AHF patients with dyspnea was stopped for futility without significant safety concerns (174)(175)(176)(177)(178).…”
Section: Medical Treatment Of Ahf Recommendationsmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.